Rathbun Joel R. 4

4 · AVIENT CORP · Filed Nov 12, 2024

Form 4

Period: 2024-11-07

SVP, Mergers & Acquisitions

Transactions

Disposition to Issuer
Common Stock
2024-11-07$51.44/sh−8,036$413,372→ 2,064 total
Exercise/Conversion
Common Stock
2024-11-07$34.10/sh+10,100$344,410→ 10,100 total
Exercise/Conversion
Common Stock
2024-11-07$31.54/sh+17,150$540,911→ 19,214 total
Disposition to Issuer
Common Stock
2024-11-07$51.45/sh−13,452$692,132→ 5,762 total
Sale
Common Stock
2024-11-07$51.45/sh−5,762$296,432→ 0 total
Exercise/Conversion
Stock Appreciation Rights
2024-11-07−10,100→ 0 total
Exercise: $34.10Exp: 2027-02-15→ Common Stock (10,100 underlying)
Exercise/Conversion
Stock Appreciation Rights
2024-11-07−17,150→ 17,150 total
Exercise: $31.54Exp: 2029-02-11→ Common Stock (17,150 underlying)

Holdings

Footnotes (4)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.44 to $51.452, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
[F2]The information in this report is based on a plan statement as of November 7, 2024.
[F3]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $34.10 per share and no more than one-third of the grant can vest per year during the first three years.
[F4]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.

Documents

1 file